Advancing Clinical Research Through Hybrid Clinical Trials and Patient Optionality

Life Sciences, Clinical Trials, Patient Recruitment & Retention,
  • Wednesday, August 14, 2024

Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies.

Historically, trials necessitated in-person participation, requiring volunteers to travel to research sites. On an average, travel times amounted to two hours, excluding the time spent at the site. Hybrid clinical trials and decentralized clinical trials are transforming the way that clinical trials are conducted by giving participants options.

Data show that these approaches are enhancing efficiency with reduced patient burden, increased patient retention and greater representative patient population. In this webinar, the expert speakers explore a range of innovative solutions and key partnerships essential for successfully conducting hybrid clinical trials. They will also share insights on how flexible solutions can propel clinical research forward through the versatility of the hybrid clinical trial optionality.

Register for this webinar today to explore the future of clinical trials through patient-centric hybrid clinical trials.

Speakers

Thad Wolfram, EmVenio Research

Thad Wolfram, President, EmVenio Research

With an extensive background in Clinical Trials and Research, Thad Wolfram joined EmVenio Research as part of an acquisition of Matrix Clinical Trials from Matrix Medical Network. As President, he is focused on the growth of decentralized trial capabilities and increased clinical trial diversity inclusion, improving the health and lives of patients.

Before joining EmVenio, he was Executive Director, Corporate Strategy and Development at PPD, leading several initiatives focused on disruption and the future of clinical trials. Thad also held various senior leadership positions in consulting centered on science and research at EY and PA Consulting Group. He earned his MBA at Rensselaer Polytechnic Institute – The Lally School of Management in Innovation and Strategic Management, an MS at Michigan State University in Industrial Microbiology / Medical Microbiology, and a BS in Microbiology and Molecular Genetics from Michigan State University.

Message Presenter
Raj Sharma, Health Wizz

Raj Sharma, Co-Founder, Health Wizz

Raj Sharma is a Co-Founder of Health Wizz, a secure platform that provides clinical researchers with the tools to identify, screen and enroll patients in clinical trials.

An accomplished executive, Raj has over 20 years of leadership experience. A passionate entrepreneur, he has extensive expertise in product and market identification, data management and distributed applications.

Previously, Raj served as President of kreateIoT, a blockchain healthcare platform acquired by Health Wizz in 2016. He served as the Chief Operations Officer and President at 3CLogic, a cloud contact center solutions provider. Before 3CLogic, Raj served as the President and Chief Executive Officer at NexTone Communications.

Raj holds an MBA from the Stern School of Business at NYU, a Master of Science in Computer Science, and a Bachelor of Engineering in Electrical Engineering from Stevens Institute of Technology.

Message Presenter

Tajuana Barron, Vice President of Project Management, PCM Trials

Tajuana Barron is the Vice President of Project Management and is responsible for project delivery. Ms. Barron joined PCM Trials in 2022 with over 30 years of clinical research experience working for pharma companies and
CROs.

Prior to joining PCM Trials, Ms. Barron served as a Senior Director of Project Management at PPD, where her responsibilities included oversight of a strategic partnership, DCT strategy and management of a team of Project Directors and Managers.

Previously, she held leadership roles at PRA and Schering Plough Research Institute (now Merck). Ms. Barron earned a Bachelor of Science in Chemistry from Bennett College and studied at the University of Medicine & Dentistry of New Jersey.

Message Presenter

Who Should Attend?

This webinar is ideal for any sponsor, CRO or clinical research professional interested in learning more about localized clinical trial options. Titles can include:

  • C-suite in Clinical Trials Management
  • Therapeutic Lead/Head
  • Clinical Development/Operations/Risk Manager
  • Innovation Lead/Head
  • Medical Director
  • Operational Director
  • Patient Advocacy/Engagement
  • Clinical Trial Feasibility
  • Project Management
  • Research and Development/Scientific Affairs
  • DEI Lead/Head
  • Site Selection/Feasibility
  • Innovative Site Solutions

What You Will Learn

Attendees will gain insights into:

  • How hybrid trials reach and diversify the participants for clinical trials
  • The approach, benefit, innovative strategies and challenges of conducting hybrid trials

Xtalks Partner

EmVenio Research

EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account